Team:Westminster/Judging

From 2012.igem.org

(Difference between revisions)
 
(13 intermediate revisions not shown)
Line 1: Line 1:
<html>
<html>
-
 
<head>
<head>
Line 22: Line 21:
font-size: 18pt;
font-size: 18pt;
margin-bottom: 0.5em;
margin-bottom: 0.5em;
 +
 +
}
}
p {
p {
Line 127: Line 128:
text-align: center;
text-align: center;
background-color: #410000;
background-color: #410000;
-
height:475px;
+
 
border-bottom:1px #000 solid;
border-bottom:1px #000 solid;
}
}
Line 204: Line 205:
}
}
.right-menu li a, .left-menu li a {background: none}
.right-menu li a, .left-menu li a {background: none}
 +
 +
#home-main-text {
 +
padding:20px 40px 20px 40px;
 +
text-align: justify;
 +
}
 +
.diary-date {
 +
font-weight: bold;
 +
width:100%;
 +
 +
}
 +
#home-main-text ul li
 +
{
 +
list-style-image: url('https://static.igem.org/mediawiki/2012/4/43/Tickmark.png');
 +
 +
}
</style>
</style>
Line 287: Line 303:
<div id="navigation">
<div id="navigation">
<ul id="navigation-list">
<ul id="navigation-list">
-
<li><a href="https://2012.igem.org/Team:Westminster" class="navlink active">Home</a></li>
+
<li><a href="https://2012.igem.org/Team:Westminster" class="navlink">Home</a></li>
<li><a href="https://2012.igem.org/Team:Westminster/Team" class="navlink">Team</a></li>
<li><a href="https://2012.igem.org/Team:Westminster/Team" class="navlink">Team</a></li>
<li class="submenu-holder">
<li class="submenu-holder">
-
<a href="https://2012.igem.org/Team:Westminster/Project/Overview"class="navlink">Project</a>
+
<a href="https://2012.igem.org/Team:Westminster/Overview"class="navlink">Project</a>
<ul class="submenu">
<ul class="submenu">
Line 301: Line 317:
<li class="submenu-button"><a href="https://2012.igem.org/Team:Westminster/Safety"class="navlink">Safety</a></li>
<li class="submenu-button"><a href="https://2012.igem.org/Team:Westminster/Safety"class="navlink">Safety</a></li>
<li class="submenu-button"><a href="https://2012.igem.org/Team:Westminster/Journal"class="navlink">Journal</a></li>
<li class="submenu-button"><a href="https://2012.igem.org/Team:Westminster/Journal"class="navlink">Journal</a></li>
-
                             </a></li>
+
                              
                    
                    
</ul>
</ul>
Line 308: Line 324:
<li><a href="https://2012.igem.org/Team:Westminster/Modeling"class="navlink">Modeling</a></li>
<li><a href="https://2012.igem.org/Team:Westminster/Modeling"class="navlink">Modeling</a></li>
<li><a href="https://2012.igem.org/Team:Westminster/Outreach"class="navlink">Outreach</a></li>
<li><a href="https://2012.igem.org/Team:Westminster/Outreach"class="navlink">Outreach</a></li>
-
                     <li><a href="https://2012.igem.org/Team:Westminster/Judging"class="navlink">Judging Criteria</a></li>
+
                     <li><a href="https://2012.igem.org/Team:Westminster/Judging"class="navlink active">Judging Criteria</a></li>
Line 323: Line 339:
<div id="the-content">
<div id="the-content">
-
<div id="home-main-image">
+
<!--div id="home-main-image">
-
<!--img src="https://static.igem.org/mediawiki/2012/4/4d/Westminster_team.png" alt="Welcome" title="Welcome to our home!" /--->
+
<img src="https://static.igem.org/mediawiki/2012/4/4d/Westminster_team.png" alt="Welcome" title="Welcome to our home!" />
-
      <div style="float:left;padding-left:30px;padding-top:50px; width:380px">
+
</div--><!-- #home-main-image -->
-
            <h1 style="text-align:left;border:none; color:#fff; position:relative;bottom:0px; left:0px; margin:0px; padding:0px 0px 20px 0px;">Fighting cancer from the inside out</h1>
+
-
<div style="color:white; text-align:justify;">Cancer recurrence is one of the fears that almost every patient undergoing chemotherapy develops. Recent findings suggest that only a small fraction of the tumor cells, called Cancer Stem Cells (CSC) are able to drive the growth of the tumor. CSC also show an increased drug resistance, and could remain unaffected after chemotherapy, eventually resulting in the formation of a new tumor.<br/><br/>
+
-
The Westminster iGEM 2012 team aims to combat cancer recurrence by using one key feature of CSCs – increased Aldehyde Dehydrogenase (ALDH) activity. We have used the promoters of 4 different ALDH isoforms present in aggressive forms of cancer to design 3 constucts that will allow us to identify, isolate and eliminate CSC, offering a novel tool for the study of this cells and a potential new anti-cancer therapy for the future.</div>
+
 +
<div id="home-main-text">
 +
<h1>Which requirements have we met?</h1><p>
 +
  <h2>Requirements for a Bronze Medal:</h2>
 +
  <ul>
 +
    <li>    Register the team.</li>
 +
    <li>Successfully complete and submit this iGEM 2012 Judging form.</li>
 +
    <li>Create and share a Description of the team's project using the iGEM wiki and the team's parts using the Registry of Standard Biological Parts.</li>
 +
    <li>Plan to present a Poster and Talk at the iGEM Jamboree.</li>
 +
    <li>Enter information detailing at least one new standard BioBrick Part or Device in the Registry of Standard Biological Parts. Including:
 +
      <ul>
 +
        <li>Primary nucleaic acid sequence.</li>
 +
        <li>Description of function.</li>
 +
        <li>Authorship.</li>
 +
        <li>Safety notes, if relevant.</li>
 +
        <li>Acknowedgment of sources and references.<br />
 +
        </li>
 +
      </ul>
 +
    </li>
 +
    <li>Submit DNA for at least one new BioBrick Part or Device to the Registry.<br />
 +
      </p>
 +
      <br />
 +
    </li>
 +
  </ul>
-
</div>
+
  <h2>Requirements for a Silver Medal:</h2>
-
<div  style="float:left; width:500px; padding-left:50px; padding-top:150px; text-align:center">
+
  <ul>
-
<img src="https://static.igem.org/mediawiki/2012/8/8a/Tumor.png" alt="Tumor" width="218" height="179" />
+
    Demonstrate that at least one new BioBrick Part or Device of your own design and construction works as expected; characterize the operation of your new part/device.</li>
-
</div>
+
    Enter this information and other documentation on both the iGEM 2012 wiki and the Registry.</li>
-
</div><!-- #home-main-image -->
+
  </ul>
-
+
 
-
+
<h2>Additional Requirements for a Gold Medal (one OR more):</h2>
-
           
+
<ul>
-
  <div id="three-column">
+
  Develop and document a new technical standard that supports the: (check all that apply)
-
 
+
     <ul>
-
  <div class="col">
+
      Outline and detail a new approach to an issue of Human Practice in synthetic biology as it relates to your project, such as safety, security, ethics, or ownership, sharing, and innovation.<br />
-
    <img src="https://static.igem.org/mediawiki/igem.org/d/d7/IntegratedDNALogo.jpg" width="146" height="61"/>
+
        </li>
-
    </div>
+
      </ul>
-
    <div class="col">
+
  </li>
-
    <img src="https://static.igem.org/mediawiki/igem.org/b/b9/GeneiousLogo.jpg" width="136" height="54"/>
+
  </ul>
-
     </div>
+
 
-
    <div class="col">
+
</div><!-- #home-main-text -->
-
    <img src="https://static.igem.org/mediawiki/igem.org/a/af/MathWorksLogo.jpg" width="202" height="40"/>
+
-
    </div>
+
-
    <div class="col">
+
-
    <img src="https://static.igem.org/mediawiki/igem.org/8/8e/AutodeskLogo.jpg" width="161" height="41"/>
+
-
    </div>
+
-
    <div class="col">
+
-
    <img src="https://static.igem.org/mediawiki/igem.org/c/c7/UniversityWestminsterLogo.jpg"/>
+
-
    </div>
+
-
   
+
-
  </div>
+
</div><!-- #the-content -->
</div><!-- #the-content -->

Latest revision as of 19:12, 12 November 2012

Which requirements have we met?

Requirements for a Bronze Medal:

  • Register the team.
  • Successfully complete and submit this iGEM 2012 Judging form.
  • Create and share a Description of the team's project using the iGEM wiki and the team's parts using the Registry of Standard Biological Parts.
  • Plan to present a Poster and Talk at the iGEM Jamboree.
  • Enter information detailing at least one new standard BioBrick Part or Device in the Registry of Standard Biological Parts. Including:
    • Primary nucleaic acid sequence.
    • Description of function.
    • Authorship.
    • Safety notes, if relevant.
    • Acknowedgment of sources and references.
  • Submit DNA for at least one new BioBrick Part or Device to the Registry.


Requirements for a Silver Medal:

    Demonstrate that at least one new BioBrick Part or Device of your own design and construction works as expected; characterize the operation of your new part/device. Enter this information and other documentation on both the iGEM 2012 wiki and the Registry.

Additional Requirements for a Gold Medal (one OR more):

    Develop and document a new technical standard that supports the: (check all that apply)
      Outline and detail a new approach to an issue of Human Practice in synthetic biology as it relates to your project, such as safety, security, ethics, or ownership, sharing, and innovation.